<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.948" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">445</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 111.160 L99.110 111.160 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M62.360 704.160 L99.110 704.160 "/>
  <g begin="text">
   <text y="76.959" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P862</text>
   <text y="87.957" x="62.362,68.86,73.36,77.356,79.858,83.854,87.85,90.352,92.854,97.354,100.351,104.347,108.847,112.348,115.345,119.341,123.337,125.587,130.087,132.589,136.585,141.589,145.09,147.34,150.337,156.835,162.838,169.336,172.333,174.583,178.579,183.079,188.083,192.079,196.075,198.577,202.573,207.577,211.573,215.569,217.819,220.321,225.325,227.575,230.572,233.074,238.078,242.578,247.078,249.58,252.082,259.579,264.079,269.083" svgx:width="0.72,0.5,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.33,0.44,0.5,0.39,0.33,0.44,0.44,0.25,0.5,0.28,0.44,0.56,0.39,0.25,0.33,0.72,0.67,0.72,0.33,0.25,0.44,0.5,0.56,0.44,0.44,0.28,0.44,0.56,0.44,0.44,0.25,0.28,0.56,0.25,0.33,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Varicella-zoster virus (VZV) experience in fingolimod </text>
   <text y="98.955" x="62.362,66.358,68.86,71.362,76.366,78.868,82.864,87.364,89.866,92.116,95.617,98.614,103.618,108.622,111.124,115.12,118.621,120.871,125.371,130.375,135.379,137.629,140.626,145.63,149.626,151.876,156.88,161.38,164.881,167.878,170.875,178.372,182.872,186.868,191.872,195.868,198.865,201.367,206.371,210.871,213.121,216.622,220.618,223.615,226.612,229.114,234.118" svgx:width="0.44,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25,0.39,0.33,0.56,0.56,0.28,0.44,0.39,0.25,0.5,0.56,0.56,0.25,0.33,0.56,0.44,0.25,0.56,0.5,0.39,0.33,0.33,0.83,0.5,0.44,0.56,0.44,0.33,0.28,0.56,0.5,0.25,0.39,0.44,0.33,0.33,0.28,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">clinical studies and the post-marketing setting</text>
   <text y="109.953" x="62.362,68.86,71.11,77.113,79.615,83.116,87.112,91.612,96.112" svgx:width="0.72,0.25,0.67,0.28,0.39,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">D Bischof</text>
   <text y="107.439" x="99.109" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="102.034,104.284,106.534,113.032,116.029,121.033,123.283,129.781,133.777,136.774,139.276,143.776,148.276" svgx:width="0.25,0.25,0.72,0.33,0.56,0.25,0.72,0.44,0.33,0.28,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, H-P Hartung</text>
   <text y="107.439" x="152.775" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="109.959" x="155.7,157.95,160.2,166.698,172.197,174.447,180.45,184.446,188.946,192.942" svgx:width="0.25,0.25,0.72,0.61,0.25,0.67,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AT Reder</text>
   <text y="107.439" x="195.939" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="109.959" x="198.864,201.114,203.364,211.365,214.866,217.116,222.615,226.611,231.111,233.613" svgx:width="0.25,0.25,0.89,0.39,0.25,0.61,0.44,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MJ Levin</text>
   <text y="107.439" x="238.112" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="109.959" x="241.037,243.287,245.537,250.541" svgx:width="0.25,0.25,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S </text>
   <text y="120.957" x="62.36,70.361,74.861,79.361,83.861,88.361,92.861,96.857,101.357,105.857,109.853" svgx:width="0.89,0.5,0.5,0.5,0.5,0.5,0.44,0.5,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Mukhopadyay</text>
   <text y="118.439" x="114.355" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="117.28,119.53,121.78,129.781,132.031,138.034,142.03,146.026,150.526,153.028,157.528,161.524,166.024,170.524,175.024,179.524,184.024" svgx:width="0.25,0.25,0.89,0.25,0.67,0.44,0.44,0.5,0.28,0.5,0.44,0.5,0.5,0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Bezuidenhoudt</text>
   <text y="118.439" x="186.525" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="189.45,191.7,193.95,200.448,202.698,207.702,212.202,214.704,218.7,223.2" svgx:width="0.25,0.25,0.72,0.25,0.56,0.5,0.28,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Putzki</text>
   <text y="118.439" x="225.702" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="129.437" x="62.364" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="131.959" x="65.287,71.29,75.79,79.786,84.286,87.787,90.289,92.791,96.292,98.542,104.041,108.541,113.041,116.542,123.04,127.54,129.79,135.289,141.787,144.037,146.287,151.786,156.286,159.787,163.783,166.285,168.535,170.785,175.285,181.288,183.79,186.292,189.793,193.789,197.29,199.792,204.292,208.792,213.292,215.542" svgx:width="0.67,0.5,0.44,0.5,0.39,0.28,0.28,0.39,0.25,0.61,0.5,0.5,0.39,0.72,0.5,0.25,0.61,0.72,0.25,0.25,0.61,0.5,0.39,0.44,0.28,0.25,0.25,0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Novartis Pharma AG, Basel, Switzerland, </text>
   <text y="129.439" x="217.791" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="131.959" x="220.716,227.214,231.21,233.712,238.212,241.713,244.215,248.211,252.711,255.708,262.206,266.202,268.704,273.204,277.2" svgx:width="0.72,0.44,0.28,0.5,0.39,0.28,0.44,0.5,0.33,0.72,0.44,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Heinrich-Heine </text>
   <text y="142.957" x="62.361,68.859,73.359,75.861,79.857,83.853,87.354,90.855,93.357,95.859,99.855,102.105,104.355,110.853,114.849,119.349,123.849,127.35,129.852,136.35,140.346,144.846,147.348,149.598,154.098,156.6,158.85,164.853,168.849,173.349,176.85,181.35,183.852,188.352,192.852,196.848,199.098,201.348,207.846,212.346,216.342,219.843,223.344,227.34,229.842,234.342,238.842,242.343,244.845,247.095,249.345,255.843,259.839,263.34,269.838,274.338,278.838,282.834,285.084" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.44,0.39,0.39,0.44,0.28,0.5,0.5,0.39,0.28,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University, Department of Neurology, Duesseldorf, Germany, </text>
   <text y="151.439" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="153.959" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,120.286,124.786,127.288,131.284,135.784,140.284,144.784,147.034,154.531,158.527,163.027,165.529,169.525,174.025,176.527,178.777,184.78,188.776,193.276,195.778,199.774,203.275,205.525,207.775,214.273,218.269,222.769,227.269,230.77,233.272,239.77,243.766,248.266,250.768,253.018,257.518,260.02" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.5,0.28,0.44,0.5,0.5,0.5,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Chicago Medical Center, Department of </text>
   <text y="164.957" x="62.362,68.365,72.361,76.861,80.362,84.862,87.364,91.864,96.364,100.36,102.61,104.86,110.863,115.363,117.865,121.861,126.361,130.861,135.361,137.611,139.861,142.858,147.862,150.112,152.362,158.86,163.36,165.862,168.364,172.36,176.86,179.11,183.61,186.112,190.612,193.114,197.11,200.611,202.861" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.67,0.5,0.28,0.44,0.5,0.5,0.5,0.25,0.25,0.33,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurology, Chicago, IL, United States, </text>
   <text y="162.439" x="205.11" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="164.959" x="208.035,214.533,219.033,221.535,225.531,229.527,233.028,236.529,239.031,241.533,245.529,247.779,252.279,254.781,257.031,263.034,267.534,270.036,274.536,278.037,282.537,287.037,291.537" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.5,0.28,0.5,0.39,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Colorado </text>
   <text y="175.957" x="62.361,67.86,72.36,75.861,79.857,84.357,88.857,91.359,94.86,97.11,104.607,108.603,113.103,115.605,119.601,124.101,126.603,128.853,134.856,139.356,145.854,150.354,154.854,158.355,160.605,162.855,169.353,173.349,177.849,182.349,185.85,188.352,194.85,198.846,203.346,205.848,208.098,212.598,215.1,217.35,222.849,226.845,231.345,233.847,238.347,240.849,244.35,246.852,250.848,253.098,256.095,260.595,263.097,267.093,271.089,273.591,276.093,280.593,285.093,288.594" svgx:width="0.61,0.5,0.39,0.44,0.5,0.5,0.28,0.39,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.5,0.72,0.5,0.5,0.39,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.61,0.44,0.5,0.28,0.5,0.28,0.39,0.28,0.44,0.25,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Anschutz Medical Campus, Department of Pediatric Infectious </text>
   <text y="186.955" x="62.361,68.859,71.361,74.862,78.858,83.358,86.859,90.855,94.356,96.606,98.856,104.355,108.855,112.356,116.856,120.357,124.857,127.107,129.357,135.36,141.858,144.108,146.358,152.856,157.356,159.858,162.36,166.356,170.856,173.106,177.606,180.108,184.608,187.11,191.106" svgx:width="0.72,0.28,0.39,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.61,0.5,0.39,0.5,0.39,0.5,0.25,0.25,0.67,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Diseases, Aurora, CO, United States</text>
   <text y="213.955" x="62.361,68.319,72.774,76.725,81.684,86.139,89.928,94.383,99.342,104.301,109.26,112.212" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="213.955" x="115.281,120.24,122.697,127.152,131.607,136.062,138.519,140.976,147.933,152.388,156.843,159.048,161.298,162.117,166.068,168.318,169.137,174.096,178.551,183.177,185.427,186.246,189.198,193.149,197.1,201.051,205.506,207.963,212.418,215.37,217.62,218.439,225.396,229.851,234.306,238.761,241.218,245.169,247.626,252.081,254.673,256.878,259.128,259.947,263.403,267.354,269.811,273.762,277.713,280.17,282.627,287.082,291.033,293.49,297.99" svgx:width="0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.55,0.44,0.25,0.55,0.56,0.5,0.56,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.25,0.25,0.55,0.39,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fingolimod, a S1P receptor modulator, selectively </text>
   <text y="224.953" x="62.361,65.313,69.264,73.719,76.176,79.632,82.089,85.041,87.498,91.953,96.408,98.865,102.816,106.272,108.189,114.147,120.6,125.055,130.086,136.044,142.002,147.96,152.415,157.446,159.363,163.818,167.769,170.226,174.681,178.632,180.549,184.5,188.955,193.41,195.327,199.278,203.229,207.684,210.141,213.093,217.044,219.501,221.418,228.375,232.326,239.283,243.738,246.69,251.145,252.9,258.192,260.109,264.06,268.011,270.468,272.925,276.381,278.298,280.755,285.21,287.127,289.584,294.039,298.035" svgx:width="0.33,0.44,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.67,0.72,0.5,0.56,0.67,0.67,0.67,0.5,0.56,0.25,0.5,0.44,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.78,0.44,0.78,0.5,0.33,0.5,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">redistributes CD4+CCR7+ naïve and central memory T cells to the </text>
   <text y="235.951" x="62.361,64.818,69.273,76.23,80.685,85.14,89.595,92.052,96.507,99.396,103.851,106.641,111.096,115.047,119.502,122.958,125.163,128.052,134.505,136.962,139.419,143.874,148.329,152.784,155.241,158.13,161.082,165.033,169.488,173.943,177.894,180.351,184.806,189.261,192.15,194.607,199.062,203.013,205.902,209.853,212.31,215.262,219.213,223.668,226.125,230.076,232.533,234.99,239.445,243.9,246.789,250.74,253.53,256.482,260.433,264.384,266.841,271.296,274.248,277.137,284.094,288.045,295.002" svgx:width="0.28,0.5,0.78,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.5,0.44,0.5,0.39,0.25,0.25,0.72,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.28,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.78,0.44,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lymphoid organs, without reducing the circulating effector mem-</text>
   <text y="246.949" x="62.361,66.816,69.768,74.223,76.383,81.675,83.997,87.948,91.899,94.356,96.813,100.269,102.474,104.796,107.748,112.203,114.525,118.476,122.931,127.386,129.843,132.795,137.25,139.707,142.164,146.115,150.57,152.892,156.843,159.3,161.757,166.212,168.669,172.62,176.571,179.028,181.35,184.806,187.263,191.718,196.173,198.63,202.581,206.037,208.242,210.564,213.021,217.476,221.427,223.749,228.204,232.659,236.61,239.562,243.513,245.97,248.427,250.749,253.206,257.661,260.613,264.564,268.515,270.972,273.429,277.884,282.339,284.661,287.613,291.564,294.021,298.017" svgx:width="0.5,0.33,0.5,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.33,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ory T cells. In controlled clinical studies, the overall infection rate </text>
   <text y="257.947" x="62.361,68.814,71.271,73.728,78.183,80.433,81.36,84.312,86.769,91.224,95.679,100.134,102.591,105.048,112.005,116.46,120.915,123.165,124.092,128.547,130.752,135.207,137.457,138.384,145.341,149.796,152.046,152.973,159.426,163.377,166.833,169.083,170.01,173.466,175.923,182.88,185.337,187.794,191.745,194.697,196.947,197.874,200.331,204.786,207.036,207.963,210.42,214.875,218.826,221.283,223.533,224.46,230.913,233.37,235.827,240.282,242.532,243.459,247.914,250.371,254.322,258.273,262.224,266.679,271.134,273.339,275.589,276.516,279.468,283.923,286.173,287.1,289.557,294.012,298.008" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with fingolimod 0.5 mg was similar to that with placebo. In the </text>
   <text y="268.945" x="62.361,66.816,71.271,74.727,77.184,80.136,87.093,91.044,93.996,98.451,102.402,104.859,107.316,111.771,116.226,118.971,122.427,126.378,128.835,131.292,133.749,138.204,142.659,145.404,148.356,153.315,161.271,166.23,169.182,171.927,174.384,178.839,181.584,186.039,190.494,194.949,199.404,201.609,204.354,208.305,211.05,214.002,217.953,220.41,224.361,226.818,229.563,233.514,237.465,240.921,244.872,247.617,252.072,255.024,257.769,261.72,264.465,268.92,272.871,275.823,278.28,282.231,286.182,288.639,291.096,295.047" svgx:width="0.5,0.5,0.39,0.28,0.33,0.78,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.39,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.33,0.56,0.89,0.56,0.33,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.44,0.25,0.33,0.44,0.28,0.44,0.28,0.25,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.44,0.25,0.5,0.44,0.33,0.28,0.44,0.44,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">post-marketing setting (PMS) in 2013, a fatal case of a varicella-</text>
   <text y="279.943" x="62.361,66.312,70.767,74.223,76.68,80.631,83.583,85.491,89.946,92.403,95.355,99.81,103.266,105.174,108.126,114.579,120.033,126.486,129.438,131.346,133.803,138.258,141.21,145.161,149.112,151.569,154.026,158.481,162.936,164.844,171.297,175.248,178.704,180.612,183.564,187.515,191.97,196.425,199.377,201.834,205.785,210.24,212.148,218.601,221.058,223.515,227.97,229.878,232.83,235.287,239.742,244.197,248.652,251.109,253.566,260.523,264.978,269.433,271.341,275.796,278.001,282.456,284.364,291.321,295.776" svgx:width="0.44,0.5,0.39,0.28,0.44,0.33,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.33,0.72,0.61,0.72,0.33,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.78,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zoster virus (VZV) infection was reported with fingolimod 0.5 mg.</text>
   <text y="290.941" x="62.361,69.363,74.367,77.364,81.36,85.356,88.353,90.855,95.355,99.351,102.852,105.849" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="290.941" x="107.667,112.536,117.036,118.854,121.851,125.847,130.347,134.847,137.844,140.346,142.164,144.666,149.166,153.162,154.98,157.977,161.973,164.475,168.471,170.289,174.285,178.785,183.285,185.103,188.604,192.6,197.1,201.096,204.093,206.595,209.097,213.597,215.415,219.915,222.912,224.568,231.066,236.565,242.901,244.719,247.221,251.721,254.718,258.714,262.71,265.212,267.714,272.214,276.714,280.215,282.033,288.531,291.033,293.535,298.035" svgx:width="0.61,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.72,0.61,0.72,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To report the rate and severity of VZV infections with </text>
   <text y="301.939" x="62.361,65.358,67.86,72.36,76.86,81.36,83.862,86.364,93.366,97.866,102.366,104.616,109.116,111.366,115.866,118.116,125.118,129.618,131.868,134.37,138.87,141.12,145.116,147.618,150.12,154.62,157.122,161.118,165.114,167.616,169.866,173.367,175.869,180.369,184.869,187.371,191.367,194.868,197.118,201.114,205.614,210.114,212.364,214.866,219.366,221.616,226.62,234.621,239.625" svgx:width="0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.78,0.5,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.56,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fingolimod 0.5 mg in clinical studies and in PMS.</text>
   <text y="312.937" x="62.361,70.767,74.673,77.58,82.494,86.904,91.818,95.229,98.136" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="312.937" x="99.918,102.825,107.235,109.017,111.429,115.839,119.745,121.527,125.433,129.843,133.749,136.161,140.571,144.477,148.383,152.793,154.575,158.481,160.893,163.305,167.715,170.127,174.033,177.939,180.351,182.133,184.545,187.452,189.864,193.77,196.182,199.593,201.753,203.535,206.442,210.348,212.76,216.666,220.077,221.859,226.269,229.176,230.958,234.864,239.274,243.684,247.59,250.497,253.908,257.814,259.596,263.502,267.912,271.818,276.228,278.64,282.051,283.833,286.74,291.15,295.056,298.053" svgx:width="0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In the analyzed clinical trials, rates of adverse events (per </text>
   <text y="323.935" x="62.361,66.771,71.181,75.591,80.001,82.251,83.205,87.615,91.521,93.933,96.345,100.251,104.661,107.073,109.98,114.39,118.296,122.202,125.109,128.52,130.68,132.93,133.884,138.798,145.206,148.113,150.363,151.317,155.223,158.13,162.036,164.286,165.24,169.65,173.556,176.967,180.873,185.283,187.533,188.487,192.897,197.307,199.557,200.511,204.921,209.331,213.741,216.153,220.059,224.469,226.719,227.673,232.083,235.989,238.401,242.307,244.557,245.511,248.418,251.325,255.735,262.647,264.897,265.851,268.263,272.673,276.579,278.829,279.783,283.689,288.099,295.011" svgx:width="0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.55,0.56,0.72,0.33,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1000 patient-years, PY) are based on pooled data from the com-</text>
   <text y="334.933" x="62.361,66.771,69.183,73.089,75.501,79.407,83.817,86.328,90.234,94.644,99.054,101.466,104.373,108.783,111.195,113.607,117.513,121.923,124.434,128.844,133.254,137.16,140.571,144.477,146.988,151.398,153.909,157.815,162.225,166.635,169.146,171.558,175.968,178.875,182.781,186.687,189.198,193.608,198.018,201.924,205.335,209.241,211.752,216.162,218.673,222.084,224.496,228.906,233.316,235.728,239.634,243.045,245.556,248.463,253.377,259.29,264.699,270.108,276.516,282.924,290.835,295.749,297.999" svgx:width="0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.56,0.67,0.61,0.61,0.72,0.72,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pleted controlled phase 2 and three phase 3 studies (FREEDOMS, </text>
   <text y="345.931" x="62.361,67.275,73.188,78.597,84.006,90.414,96.822,104.733,109.647,111.897,112.86,115.767,118.674,120.924,121.887,125.793,130.203,134.613,136.863,137.664,143.073,148.986,155.394,161.802,166.716,171.63,178.038,183.951,191.862,196.776,199.683,201.933,202.896,206.802,211.212,215.622,217.872,218.835,221.247,225.657,229.563,231.975,234.882,237.132,238.095,240.507,244.917,249.327,253.737,256.644,259.056,262.962,265.869,272.781,275.031,275.994,279.9,284.31,286.722,290.628,295.038" svgx:width="0.56,0.67,0.61,0.61,0.72,0.72,0.89,0.56,0.25,0.55,0.33,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.67,0.72,0.72,0.56,0.56,0.72,0.67,0.89,0.56,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.28,0.5,0.5,0.5,0.33,0.28,0.44,0.33,0.78,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">FREEDOMS II and TRANSFORMS) and their long-term exten-</text>
   <text y="356.929" x="62.361,65.772,68.184,72.594,77.004,80.415,82.575,84.501,87.408,91.818,93.744,98.658,106.569,111.483,113.643,115.569,121.977,125.883,127.809,131.715,136.125,140.031,142.443,146.853,150.759,153.171,157.077,161.487,163.413,165.825,170.235,174.141,176.067,179.973,184.383,191.295,195.705,198.117,202.023,204.435,206.847,211.257,215.163,217.089,219.996,223.902,228.312,232.722,235.629,238.041,240.453,244.863,249.273,251.199,254.106,258.012,260.424,264.33,266.256,270.162,274.572,278.478,281.385,285.795,287.721,291.132,293.544,298.044" svgx:width="0.39,0.28,0.5,0.5,0.39,0.25,0.25,0.33,0.5,0.25,0.56,0.89,0.56,0.25,0.25,0.72,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.25,0.44,0.5,0.44,0.33,0.5,0.25,0.39,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sions. In PMS, we evaluated the cumulative reporting rate every six </text>
   <text y="367.927" x="62.361,69.273,73.683,78.093,80.505,84.915,88.326,90.882,94.293,96.705,101.115,105.021,108.927,111.492,115.902,120.312,124.722,129.132,131.292,133.695,141.381,145.287,147.852,151.758,154.17,157.581,161.991,164.556,167.463,171.369,175.779,180.189,183.096,185.508,188.073,192.483,196.389,198.801,202.707,205.272,209.682,214.092,216.495,222.903,228.312,234.558,237.123,240.03,243.936,247.842,251.748,254.16,256.572,260.982,264.888,267.3,269.712,274.122,278.532,281.097,284.004,288.414,292.32,295.02" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.39,0.28,0.5,0.44,0.44,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.94,0.44,0.25,0.44,0.28,0.39,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.25,0.5,0.44,0.28,0.44,0.25,0.5,0.5,0.25,0.72,0.61,0.72,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months since 2010. We also report data on VZV reactivation (her-</text>
   <text y="378.925" x="62.361,66.771,70.677,74.088,76.248,80.154,84.564,87.975,90.387,94.293,96.84,99.0,101.16,107.568,112.977,115.884,118.044,122.454,126.864,129.024,132.435,136.341,140.751,144.657,147.564,149.976,152.388,156.798,158.958,162.864,167.274,171.684,173.844,177.75,180.162,182.574,186.984,189.396,193.302,197.208,199.62,201.78,205.686,210.096,217.008,221.418,223.83,226.242,230.148,234.054,236.466,238.878,243.288,247.698" svgx:width="0.5,0.44,0.39,0.25,0.44,0.5,0.39,0.28,0.44,0.33,0.25,0.25,0.72,0.61,0.33,0.25,0.5,0.5,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pes zoster, HZ) by severity and clinical complication.</text>
   <text y="389.923" x="62.361,68.769,72.675,76.086,81.0,83.412,86.319,89.73,92.637" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="389.923" x="95.814,102.222,105.633,107.883,108.81,113.22,116.127,118.377,119.304,123.714,128.124,130.374,131.301,136.215,140.121,144.531,146.781,147.708,152.118,156.528,160.938,165.348,167.508,169.758,170.685,177.597,182.007,184.914,188.82,191.07,191.997,194.409,198.819,202.725,207.135,209.385,210.312,214.722,219.132,221.292,225.702,230.112,234.522,236.772,237.699,242.109,246.015,248.427,250.839,254.745,259.155,261.567,264.978,267.228,268.155,271.062,274.968,278.874,282.78,285.192,289.602,293.508,298.008" svgx:width="0.72,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.56,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.78,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">As of 28 Feb 2014, more than 91,500 patients received </text>
   <text y="400.921" x="62.361,65.268,67.68,72.09,76.5,80.91,83.322,85.734,92.646,97.056,101.466,103.977,106.389,110.799,113.31,117.216,119.628,122.04,126.45,128.862,132.768,136.674,139.086,141.597,144.009,146.916,149.328,153.234,155.646,159.057,161.568,165.474,169.884,174.294,176.805,179.217,183.627,187.533,190.044,194.958,202.869,207.783,210.294,216.702,219.114,221.526,225.936,228.447,232.353,234.765,237.276,239.688,243.594,247.5,250.911,253.323,255.834,260.244,264.654,269.064,271.224,275.634,280.044,284.454,286.965,291.879,298.044" svgx:width="0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.56,0.89,0.56,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.56,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fingolimod in clinical trials and the PMS with at least 135,800 PY </text>
   <text y="411.919" x="62.361,66.771,69.678,71.928,73.107,77.013,81.423,85.833,90.243,93.654,98.064,100.971,104.877,107.037,109.287,110.466,116.874,120.78,123.192,127.098,129.348,130.527,133.434,136.341,140.751,147.663,149.913,151.092,154.998,159.408,163.818,166.23,169.137,173.547,175.959,178.371,182.277,186.687,188.937,190.116,194.022,196.434,198.846,203.256,205.668,209.574,213.48,215.892,218.142,219.321,221.733,224.64,227.052,230.958,233.37,236.781,239.031,240.21,243.621,248.031,252.441,258.849,262.755,267.165,269.415,270.594,273.006,277.416,281.322,283.734,285.984,287.163,289.575,293.985,297.981" svgx:width="0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.25,0.55,0.72,0.44,0.28,0.44,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of exposure. Data from controlled clinical trials showed that the </text>
   <text y="422.917" x="62.361,65.268,69.174,71.586,75.492,78.903,80.91,85.32,88.227,90.072,96.48,101.889,108.135,110.142,112.554,116.964,119.871,123.777,127.683,130.095,132.507,136.917,141.327,144.738,146.745,153.153,157.059,159.966,163.872,165.879,169.956,174.366,176.373,182.781,185.193,187.605,192.015,194.022,196.929,199.341,203.751,208.161,212.571,214.983,217.395,224.307,228.717,233.127,235.134,239.544,241.704,246.114,248.121,255.033,259.443,261.45,265.86,269.271,271.431,273.438,277.848,280.26,284.67,289.08,293.49,297.99" svgx:width="0.33,0.44,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.72,0.61,0.72,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.78,0.5,0.25,0.5,0.39,0.25,0.25,0.5,0.28,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rates of VZV infections were 11 with fingolimod 0.5 mg vs. 6/1000 </text>
   <text y="433.915" x="62.361,67.275,73.35,75.6,76.734,83.142,85.554,87.966,92.376,94.626,95.76,100.17,102.582,106.488,110.394,114.3,118.71,123.12,125.28,127.53,128.664,132.57,136.98,141.39,143.64,144.774,151.182,155.088,157.995,161.901,164.151,165.285,169.695,174.105,178.011,182.421,186.327,190.737,195.147,199.053,203.463,205.713,206.847,209.259,213.669,215.919,217.053,219.465,223.875,227.781,230.031,231.165,235.071,239.481,241.893,245.799,250.209,253.62,256.032,260.442,264.852,267.102,268.236,271.143,275.553,279.963,282.213,283.347,285.759,290.169,292.419,293.553,298.053" svgx:width="0.56,0.72,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PY with placebo, and were unchanged in the extension (up to 7 </text>
   <text y="444.913" x="62.361,66.771,70.677,74.583,77.49,80.901,83.808,86.31,90.72,95.13,99.036,102.447,106.353,109.764,111.924,114.426,117.333,121.743,124.245,126.657,131.067,134.973,137.475,141.381,145.791,150.201,152.613,155.52,159.93,162.342,164.754,168.66,173.07,175.572,179.982,184.392,188.298,191.709,195.615,199.026,201.528,205.938,208.845,211.347,215.253,217.665,220.077,224.487,226.899,230.805,234.711,237.123,239.625,242.037,244.944,247.356,251.262,253.674,257.085,259.245,261.747,266.157,270.567,274.473,278.883,285.795,290.205,292.617,295.029" svgx:width="0.5,0.44,0.44,0.33,0.39,0.33,0.25,0.5,0.5,0.44,0.39,0.44,0.39,0.25,0.25,0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.5,0.5,0.44,0.5,0.78,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">years) phases. In the controlled phases of clinical trials, uncompli-</text>
   <text y="455.911" x="62.361,66.267,70.173,72.585,76.491,80.901,83.151,84.384,88.29,92.7,95.112,99.018,103.428,107.334,111.744,116.154,119.565,121.815,123.048,129.456,134.865,137.115,138.348,142.254,146.664,151.074,154.485,156.897,159.309,161.721,166.131,168.543,172.449,176.859,179.109,180.342,184.752,189.162,196.569,198.819,200.052,204.462,207.369,209.619,210.852,214.758,217.17,219.582,221.832,223.065,226.971,230.877,234.288,238.194,241.605,243.855,245.088,247.995,252.405,256.815,258.975,263.385,265.797,270.207,274.617,279.027,283.437,285.687,286.92,291.834,297.999" svgx:width="0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.44,0.5,0.5,0.39,0.25,0.55,0.72,0.61,0.25,0.55,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.56,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cated cutaneous HZ constituted 95% of all cases (10.4/1000 PY </text>
   <text y="466.909" x="62.361,68.769,71.181,73.593,78.003,80.253,82.854,85.761,88.173,92.583,96.993,101.403,103.815,106.227,113.139,117.549,121.959,124.209,126.81,131.22,133.38,137.79,140.04,142.641,149.553,153.963,156.87,159.282,161.532,164.133,168.543,172.953,175.203,177.804,181.71,185.616,189.027,192.933,196.344,198.594,201.195,205.605,208.512,210.762,213.363,217.773,220.185,223.596,227.007,230.913,237.825,240.237,244.647,248.553,250.965,254.871,259.281,261.531,264.132,270.54,275.949,278.199,280.8,287.208,291.114,294.021,298.017" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.78,0.5,0.33,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.39,0.44,0.78,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.61,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with fingolimod 0.5 mg); no cases of disseminated HZ were </text>
   <text y="477.907" x="62.361,65.268,69.174,73.584,77.994,80.901,83.313,87.219,91.629,93.879,95.283,101.691,104.103,106.515,110.925,113.175,114.579,118.989,121.149,125.559,127.809,129.213,136.125,140.535,142.695,144.945,146.349,149.256,153.666,155.916,157.32,162.234,170.145,175.059,177.219,179.469,180.873,183.285,187.695,191.601,193.851,195.255,199.161,203.571,210.483,214.893,217.305,221.211,223.623,226.035,230.445,234.351,236.601,238.005,240.912,244.818,249.228,253.638,256.545,258.957,261.369,265.779,270.189,272.439,273.843,276.75,280.656,283.068,286.974,289.224,290.628,295.038,298.035" svgx:width="0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.78,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.56,0.89,0.56,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reported with 0.5 mg. In PMS, the cumulative reporting rate of </text>
   <text y="488.905" x="62.361,68.769,74.178,80.424,82.638,85.05,89.46,92.367,96.273,100.179,102.591,105.003,109.413,113.823,117.234,119.448,125.856,129.762,133.173,135.387,139.797,141.957,146.367,148.779,153.189,157.599,162.009,166.419,168.633,173.547,179.622,181.836,185.742,190.152,194.562,196.776,199.188,203.598,207.504,209.718,212.625,216.531,218.943,222.849,226.26,228.474,232.884,236.79,241.2,245.106,247.32,250.227,254.133,261.045,264.951,267.363,271.773,275.679,280.089,282.303,286.209,290.619,295.029" svgx:width="0.72,0.61,0.72,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.5,0.25,0.56,0.72,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">VZV infections was 7.2/1000 PY and the rates have remained con-</text>
   <text y="499.903" x="62.361,65.772,68.184,71.595,74.007,77.913,82.323,84.735,86.895,88.713,94.122,98.532,102.438,104.418,108.828,113.238,117.144,120.051,123.957,126.369,128.781,130.761,133.668,137.574,141.984,146.394,149.301,151.713,154.125,158.535,162.945,164.925,167.832,171.738,174.15,178.056,180.036,184.446,187.353,189.333,193.239,197.649,204.561,208.971,211.383,213.795,217.701,221.607,224.019,227.925,232.335,234.315,240.723,246.132,248.112,250.524,253.935,255.915,259.821,263.232,265.644,268.056,274.968,278.874,281.286,285.192,289.602,291.582,295.488,297.99" svgx:width="0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.44,0.5,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.61,0.25,0.28,0.39,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sistent. The overall reporting rate of complicated HZ is estimated at </text>
   <text y="510.901" x="62.361,66.267,70.677,75.087,79.497,81.909,84.213,88.623,90.783,95.193,97.605,102.015,106.425,110.835,115.245,117.549,122.463,127.71,129.87,132.174,138.087,141.993,145.404,149.31,153.72,156.024,160.434,164.844,167.148,171.054,175.464,179.37,181.782,186.192,189.603,192.015,195.426,197.73,200.637,203.544,207.954,214.866,217.17,219.582,223.992,227.898,230.202,235.116,241.524,247.437,249.741,253.647,258.057,262.467,266.373,269.28,272.691,276.597,278.901,282.807,287.217,291.123,295.533,298.035" svgx:width="0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.5,0.25,0.56,0.72,0.25,0.25,0.67,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.56,0.72,0.72,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">about 0.3/1000 PY. Based on analysis from the FDA adverse event </text>
   <text y="521.899" x="62.361,65.268,69.174,73.584,77.994,80.901,83.313,85.725,90.135,94.545,97.056,100.467,104.877,108.288,110.7,114.606,121.518,124.029,128.439,132.345,134.757,138.663,143.073,146.979,150.39,154.296,156.456,158.967,161.379,165.789,169.695,172.206,176.616,179.523,183.933,188.343,192.753,195.66,198.072,200.484,204.894,209.304,211.815,216.225,219.132,221.643,225.054,228.96,231.867,234.279,238.689,243.099,246.51,249.021,255.429,260.838,263.349,265.761,270.171,273.078,276.984,280.89,283.302,285.714,290.124,294.534,298.035" svgx:width="0.33,0.44,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.39,0.44,0.25,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.39,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.72,0.61,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reporting system database, the proportion of serious HZ infections </text>
   <text y="532.897" x="62.361,66.771,71.181,73.431,74.313,77.22,79.632,84.042,88.452,92.862,95.274,97.686,104.598,109.008,113.418,115.668,116.55,118.962,122.373,124.623,125.505,129.411,133.821,140.733,145.143,149.049,151.956,155.862,160.272,162.684,166.59,168.84,169.722,172.134,176.544,178.794,179.676,184.086,186.498,190.908,194.814,197.721,199.971,200.853,208.764,213.678,215.928,216.81,223.218,231.129,235.908,239.319,241.479,243.729,244.611,251.019,255.429,259.839,262.746,266.652,271.062,273.474,277.38,281.79,285.696,290.106,294.516,298.017" svgx:width="0.5,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.72,0.89,0.61,0.39,0.25,0.25,0.55,0.72,0.5,0.5,0.33,0.44,0.5,0.28,0.44,0.5,0.44,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on fingolimod is comparable to other MS DMTs. Non-cutaneous </text>
   <text y="543.895" x="62.361,69.273,73.179,77.589,80.001,82.908,86.814,90.225,92.637,96.543,98.955,101.367,105.777,110.187,113.598,115.848,117.45,123.858,127.764,130.671,134.577,136.827,138.429,142.839,147.249,151.155,155.565,162.477,169.389,173.799,178.209,180.369,182.619,184.221,190.629,195.039,197.451,201.861,204.111,205.713,209.619,211.869,213.471,216.378,220.284,226.692,228.942,230.544,234.45,238.356,241.767,245.673,249.084,251.334,252.936,257.346,260.253,262.503,264.105,267.012,270.918,274.824,279.234,282.141,285.048,288.954,293.364,295.776,298.026" svgx:width="0.78,0.44,0.5,0.28,0.33,0.44,0.39,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.72,0.25,0.55,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">manifestations were uncommon. Only a few cases of recurrent, </text>
   <text y="554.893" x="62.361,66.771,71.181,75.591,78.498,81.909,85.815,88.722,91.134,95.544,99.954,103.365,105.525,109.935,113.841,116.748,123.66,127.566,129.978,134.388,141.3,145.206,147.618,149.778,156.186,161.595,163.755,167.661,171.567,174.978,178.884,182.295,184.455,188.865,192.771,197.181,201.087,203.247,207.657,211.563,215.469,219.879,222.039,224.946,228.852,233.262,237.672,240.579,242.991,246.897,251.307,253.467,255.879,260.289,262.449,266.859,270.765,273.177,277.083" svgx:width="0.5,0.5,0.5,0.33,0.39,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.5,0.44,0.33,0.78,0.44,0.28,0.5,0.78,0.44,0.28,0.25,0.72,0.61,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">non-serious dermatomal HZ cases have been reported to date.</text>
   <text y="565.891" x="62.361,68.814,73.269,78.228,82.179,84.636,89.595,93.051,95.508,99.963,104.922,108.378,111.33" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="565.891" x="113.337,119.295,123.246,125.703,129.654,133.11,135.117,139.572,142.524,144.369,150.822,156.276,162.567,164.574,167.031,171.486,174.438,178.389,182.34,184.797,187.254,191.709,196.164,199.62,201.627,204.084,208.539,210.546,213.498,215.955,220.41,224.865,229.32,231.777,234.234,241.191,245.646,250.101,252.108,256.059,258.516,260.973,265.428,267.885,271.836,275.787,278.244,280.251,282.708,285.66,288.117,292.068,294.525,298.026" svgx:width="0.67,0.44,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.72,0.61,0.72,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Rates of VZV infections in fingolimod clinical trials </text>
   <text y="576.889" x="62.361,68.814,72.765,75.717,79.668,81.495,83.952,88.407,94.86,96.687,103.14,105.597,108.054,112.509,114.336,117.288,119.745,124.2,128.655,133.11,135.567,138.024,144.981,149.436,153.891,155.718,160.173,162.378,166.833,168.66,175.617,180.072,182.277,184.104,188.559,193.014,195.471,197.298,201.753,204.21,208.665,213.12,217.071,220.023,221.85,224.307,228.762,232.713,237.168,238.995,241.452,245.907,247.734,252.189,254.646,258.597,262.548,266.499,270.954,275.409,277.236,280.188,284.139,288.09,290.547,295.002" svgx:width="0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.72,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.78,0.5,0.25,0.25,0.5,0.5,0.28,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were low with fingolimod 0.5 mg, but higher than in placebo recip-</text>
   <text y="587.887" x="62.361,64.818,68.769,73.224,75.681,79.137,81.342,83.817,90.27,95.724,102.015,104.652,107.109,111.564,114.516,118.467,122.418,124.875,127.332,131.787,136.242,138.879,141.831,145.782,148.239,152.19,155.646,158.283,161.235,165.186,172.143,176.094,178.551,183.006,186.957,191.412,194.049,197.505,199.962,203.913,208.368,210.825,214.776,217.413,221.868,226.323,230.274,233.226,235.863,238.32,240.777,247.734,251.685,254.322,256.779,261.234,263.871,267.822,272.277,274.734,278.685,283.14,286.596,289.053,293.508,298.008" svgx:width="0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.72,0.61,0.72,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.5,0.5,0.44,0.33,0.25,0.28,0.28,0.78,0.44,0.25,0.28,0.5,0.25,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ients. VZV infection rates remained stable over time in extension </text>
   <text y="598.885" x="62.361,65.817,68.274,72.729,77.184,79.641,83.592,87.048,89.298,93.249,97.704,102.159,104.409,109.368,117.324,122.283,124.488,126.576,132.03,136.485,140.436,143.892,147.843,150.093,154.044,157.995,161.451,165.402,168.858,171.108,177.561,181.512,184.464,188.415,190.665,197.622,202.077,205.533,207.99,210.447,214.902,217.152,221.607,226.062,230.013,234.468,241.425,245.88,248.337,250.794,254.745,258.696,261.153,265.104,269.559,271.809,275.76,280.215,282.672,286.623,291.078,295.029" svgx:width="0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.56,0.89,0.56,0.25,0.25,0.61,0.5,0.44,0.39,0.44,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.78,0.5,0.39,0.28,0.28,0.5,0.25,0.5,0.5,0.44,0.5,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.28,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">studies and PMS. These cases were mostly uncomplicated cutane-</text>
   <text y="609.883" x="62.361,66.816,71.271,74.727,76.977,78.93,85.383,90.837,93.042,95.292,97.083,102.537,106.992,110.943,113.193,115.146,118.098,120.555,124.011,128.466,130.716,132.669,137.124,140.076,142.326,144.117,150.57,156.024,162.315,164.565,166.518,168.975,173.43,176.382,180.333,184.284,186.741,189.198,193.653,198.108,201.564,203.814,205.767,208.224,211.68,213.93,215.883,222.336,226.287,228.744,231.201,233.451,235.404,242.361,246.312,250.767,254.718,259.173,263.124,267.075,271.53,273.987,277.938,280.188,282.141,288.594,291.051,293.508,298.008" svgx:width="0.5,0.5,0.39,0.25,0.55,0.72,0.61,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.61,0.72,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.39,0.25,0.55,0.72,0.44,0.28,0.28,0.25,0.55,0.78,0.44,0.5,0.44,0.5,0.44,0.44,0.5,0.28,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ous HZ. The risk of VZV infections is well manageable with </text>
   <text y="620.881" x="62.361,66.312,70.767,75.222,78.174,82.629,87.084,90.036,92.493,96.444,98.901,102.852,105.102,106.227,110.682,113.139,117.594,120.051,122.508,126.459,130.914,134.865,138.816,141.066,142.191,145.143,149.598,152.55,154.8,155.925,159.381,161.838,166.293,170.748,174.204,176.661,180.117,184.572,191.529,195.984,198.441,202.896,209.853,213.309,215.559,216.684,221.139,224.091,226.341,227.466,229.923,234.378,237.33,241.281,245.232,247.689,250.146,254.601,259.056,262.512,264.762,265.887,269.838,274.293,278.748,280.998,282.123,288.576,291.033,293.49,297.99" svgx:width="0.44,0.5,0.5,0.33,0.5,0.5,0.33,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.39,0.28,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">appropriate vigilance for signs/symptoms of infections and with </text>
   <text y="631.879" x="62.361,66.312,68.769,72.72,76.671,79.623,81.828,84.78,88.731,92.682,97.137,104.094,111.051,115.002,119.457,123.912,127.863,130.32,132.777,137.232,141.687,145.143,147.348,151.803,156.258,158.463,160.92,167.877,174.834,179.289,183.744,186.201,190.152,194.103,196.56,199.017,203.472,207.927,210.132,214.083,218.538,222.489,224.946,229.401,232.857,235.314,237.519,241.974,245.925,248.877,251.334,255.285,259.236,261.693,264.15,268.101" svgx:width="0.44,0.28,0.44,0.44,0.33,0.25,0.33,0.44,0.44,0.5,0.78,0.78,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.5,0.44,0.33,0.28,0.44,0.44,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clear recommendations on immunization against varicella.</text>
   <text y="658.879" x="62.361,67.86,72.36,76.86" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P863</text>
   <text y="669.877" x="62.361,68.364,72.36,76.356,80.856,83.853,91.35,95.346,100.35,103.347,105.597,110.097,113.094,115.344,122.841,127.845,130.347,133.344,135.846,140.85,143.352,147.348,149.598,153.099,157.095,159.597,163.593,167.589,172.089,175.59,178.092,181.593,183.843,188.847,193.347,196.344,198.846,202.842,207.846,210.843,214.344,216.594,221.094,224.091,227.088,231.084,235.08,237.33,241.83,246.33" svgx:width="0.67,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.25,0.5,0.33,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.5,0.33,0.33,0.44,0.44,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Treatment of multiple sclerosis patients after 24 </text>
   <text y="680.875" x="62.361,68.859,73.359,76.356,80.856,83.358,85.86,89.856,94.86,102.357,106.857,111.861,114.111,119.115,123.615,127.116,131.112,134.613,137.61,139.86,144.36,146.61,151.614,155.61,160.11,163.611,168.615,172.611,176.607,179.604,182.106,186.606,190.602,192.852,197.352,202.356,205.857,209.853,213.849,218.349,222.849,225.846,228.348,232.848,237.852,242.352,244.854,247.104,250.605,253.602,258.606,263.61,268.11,271.107" svgx:width="0.72,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.25,0.56,0.5,0.39,0.44,0.39,0.33,0.25,0.5,0.25,0.56,0.44,0.5,0.39,0.56,0.44,0.44,0.33,0.28,0.5,0.44,0.25,0.5,0.56,0.39,0.44,0.44,0.5,0.5,0.33,0.28,0.5,0.56,0.5,0.28,0.25,0.39,0.33,0.56,0.56,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Natalizumab doses: a prospective observational study: </text>
   <text y="691.873" x="62.361,65.358,70.362,74.358,76.608,82.611,89.109,92.106,97.11,103.113,110.115" svgx:width="0.33,0.56,0.44,0.25,0.67,0.72,0.33,0.56,0.67,0.78,0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">the TY-STOP</text>
   <text y="702.871" x="62.361,70.362,72.612,78.615,81.117,85.113,88.11,90.612,94.608" svgx:width="0.89,0.25,0.67,0.28,0.44,0.33,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M Clerico</text>
   <text y="700.439" x="99.109" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="702.959" x="102.034,104.284,106.534,109.531,111.781,116.785,120.781,125.281,127.783,131.779,136.279,140.275,142.777,145.279" svgx:width="0.25,0.25,0.33,0.25,0.56,0.44,0.5,0.28,0.44,0.5,0.44,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, I Schiavetti</text>
   <text y="700.439" x="147.78" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="702.959" x="150.705,152.955,155.205,160.209,165.213,167.463,173.961,177.957,180.207,188.208,192.204,195.201,199.197,203.193,207.693,210.195" svgx:width="0.25,0.25,0.56,0.56,0.25,0.72,0.44,0.25,0.89,0.44,0.33,0.44,0.44,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, SF De Mercanti</text>
   <text y="700.439" x="212.696" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="702.959" x="215.621,217.871,220.121,225.125,227.375,232.379,234.881,238.877,242.873,246.869" svgx:width="0.25,0.25,0.56,0.25,0.56,0.28,0.44,0.44,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Piazza</text>
   <text y="700.439" x="250.865" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="702.959" x="253.79,256.04,258.29" svgx:width="0.25,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="713.957" x="62.36,68.858,71.108,77.606,82.106,86.102" svgx:width="0.72,0.25,0.72,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">D Gned</text>
   <text y="711.439" x="90.604" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="713.959" x="93.529,95.779,98.029,104.527,106.777,112.78,115.777,119.773,123.274,127.27,129.772,133.768,136.018,144.019,148.519,151.516,154.513" svgx:width="0.25,0.25,0.72,0.25,0.67,0.33,0.44,0.39,0.44,0.28,0.44,0.25,0.89,0.5,0.33,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, V Brescia Morra</text>
   <text y="711.439" x="158.508" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="713.959" x="161.433,163.683,165.933,171.936,174.186,179.685,183.681,188.181,192.177,194.679,197.181,199.683" svgx:width="0.25,0.25,0.67,0.25,0.61,0.44,0.5,0.44,0.28,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Lanzillo</text>
   <text y="711.439" x="204.182" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="713.959" x="207.107,209.357,211.607,218.105,220.355,226.853,231.353,235.349,239.345,243.341" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.44,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Ghezzi</text>
   <text y="711.439" x="245.843" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="713.959" x="248.768,251.018,253.268" svgx:width="0.25,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="724.957" x="62.36,68.858,71.108,77.111,79.613,83.609,88.109,92.105,96.605" svgx:width="0.72,0.25,0.67,0.28,0.44,0.5,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Bianchi</text>
   <text y="722.439" x="99.109" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="724.959" x="102.034,104.284,106.534,113.032,115.282,120.286,124.282,126.784,130.78,137.782" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.28,0.44,0.78,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Salemi</text>
   <text y="722.439" x="140.283" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="724.959" x="143.208,145.458,147.708,152.712,154.962,160.965,164.961,168.957,171.459,178.461,182.961,185.463" svgx:width="0.25,0.25,0.56,0.25,0.67,0.44,0.44,0.28,0.78,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Realmuto</text>
   <text y="722.439" x="189.963" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="724.959" x="192.888,195.138,197.388,202.392,204.642,209.646,214.146,216.648" svgx:width="0.25,0.25,0.56,0.25,0.56,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Sola</text>
   <text y="722.439" x="220.644" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="724.959" x="223.569,225.819,228.069,233.073,235.323,241.821,244.323,246.825,250.821,253.323,255.825" svgx:width="0.25,0.25,0.56,0.25,0.72,0.28,0.28,0.44,0.28,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Vitetta</text>
   <text y="722.439" x="259.82" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="724.959" x="262.745,264.995,267.245" svgx:width="0.25,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 715.300 L354.250 715.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,315.02,317.27,323.273,327.269,331.769,335.765,338.267,340.769" svgx:width="0.56,0.25,0.67,0.44,0.5,0.44,0.28,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">P Cavalla</text>
   <text y="74.583" x="344.764" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">7</text>
   <text y="77.103" x="347.689,349.939,352.189,358.687,360.937,365.941,370.441,374.941,378.937,381.934,384.436" svgx:width="0.25,0.25,0.72,0.25,0.56,0.5,0.5,0.44,0.33,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Superti</text>
   <text y="74.583" x="386.938" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">7</text>
   <text y="77.103" x="389.863,392.113,394.363,400.861,403.111,408.115,412.111,415.108,418.105,422.101,425.098" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.33,0.33,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Ferraro</text>
   <text y="74.583" x="429.597" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="77.103" x="432.522,434.772,437.022,443.52,445.77,450.774,454.77,459.27,461.772,464.274,468.27,472.266,474.768,477.27" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Paolicelli</text>
   <text y="74.583" x="479.772" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">8</text>
   <text y="77.103" x="482.697,484.947,487.197,495.198,497.448,502.947,505.944,510.444,512.946,516.942,521.442" svgx:width="0.25,0.25,0.89,0.25,0.61,0.33,0.5,0.28,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Trojano</text>
   <text y="74.583" x="525.941" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">8</text>
   <text y="77.103" x="528.866,531.116" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="88.101" x="310.013,318.014,323.018,325.268,330.272,334.772,337.769,344.771,348.767,353.267" svgx:width="0.89,0.56,0.25,0.56,0.5,0.33,0.78,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MP Sormani</text>
   <text y="85.583" x="355.771" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="88.103" x="358.696,360.946,363.196,368.695,370.945,377.443,381.943,384.94,388.936,391.438,393.94" svgx:width="0.25,0.25,0.61,0.25,0.72,0.5,0.33,0.44,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Durelli</text>
   <text y="85.583" x="396.442" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="96.581" x="310.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="99.103" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,357.185,359.687,361.937,366.941,371.441,374.942,377.444,381.944,386.444,388.694,390.944,397.442,400.943,405.443,409.943,413.444,416.945,421.445,425.945,430.445,432.695,434.945,437.942,440.444,444.944,447.446,451.442,453.692" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.56,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.72,0.39,0.5,0.5,0.39,0.39,0.5,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Torino, Orbassano, Italy, </text>
   <text y="96.583" x="455.94" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="99.103" x="458.865,464.364,466.866,471.366,474.867,477.369,481.869,484.371,486.873,490.374,492.876,495.378,499.374,502.875,505.125,511.623,516.123,518.625,521.128" svgx:width="0.61,0.28,0.5,0.39,0.28,0.5,0.28,0.28,0.39,0.28,0.28,0.44,0.39,0.25,0.72,0.5,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biostatistics Unit </text>
   <text y="110.101" x="310.014,316.512,320.508,325.008,329.508,333.009,335.511,342.009,346.005,350.505,353.007,355.257,359.757,362.259,364.509,371.007,375.003,379.503,382.005,384.507,389.007,391.257,395.757,399.753,402.255,406.251,410.751,414.747,418.743,422.244,424.494,427.491,433.989,436.986,441.486,445.986,451.485,456.489,459.486,461.736,463.986,470.484,474.48,478.98,483.48,487.98,490.23,492.48,495.477,497.979,502.479,504.982,508.978,511.228" svgx:width="0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.39,0.25,0.33,0.72,0.33,0.5,0.5,0.61,0.56,0.33,0.25,0.25,0.72,0.44,0.5,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Department of Health Sciences (DISSAL), Genoa, Italy, </text>
   <text y="118.583" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="121.103" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,357.185,359.687,361.937,367.94,372.44,376.94,379.442,383.438,386.939,389.189,391.439,397.442,401.942,406.442,408.944,412.94,416.441,418.691,420.941,423.938,426.44,430.94,433.442,437.438,439.688" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.67,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Naples, Naples, Italy, </text>
   <text y="118.583" x="441.936" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="121.103" x="444.861,452.358,456.858,459.108,465.111,469.107,473.607,476.109,480.105,483.606,485.856,488.106,492.606,497.106,501.606,504.108,507.105,509.355,514.854,519.354,521.856,526.356,530.856,533.358,537.858" svgx:width="0.83,0.5,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.5,0.5,0.5,0.28,0.33,0.25,0.61,0.5,0.28,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MS Center, Sant’ Antonio </text>
   <text y="132.101" x="310.014,315.513,320.013,324.513,327.015,331.011,333.261,339.759,344.259,347.76,352.26,354.762,357.264,361.764,364.266,366.516,368.766,375.264,379.26,383.76,388.26,391.761,394.263,400.761,404.757,409.257,411.759,414.009,418.509,421.011,423.261,429.264,433.26,437.76,441.261,445.761,448.263,452.763,457.263,461.259,463.509,465.759,472.257,476.757,479.259,481.761,486.261,489.762,494.262,496.764,500.76,503.01,505.26,508.257,510.759,515.259,517.761,521.757,524.007" svgx:width="0.61,0.5,0.5,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.5,0.39,0.5,0.28,0.44,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Abate Hospital, Department of Neurology, Gallarate, Italy, </text>
   <text y="140.583" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="143.103" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,357.185,359.687,361.937,367.436,371.936,374.438,378.434,381.935,388.433,392.933,395.183,397.433,402.932,407.432,409.934,413.93,417.431,423.929,428.429,430.679,432.929,435.926,438.428,442.928,445.43,449.426,451.676" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.61,0.5,0.28,0.44,0.39,0.72,0.5,0.25,0.25,0.61,0.5,0.28,0.44,0.39,0.72,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Palermo, Palermo, Italy, </text>
   <text y="140.583" x="453.924" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">6</text>
   <text y="143.103" x="456.849,463.347,467.847,470.349,474.345,478.341,481.842,485.343,487.845,490.347,494.343,496.593,501.093,503.595,505.845,513.342,517.842,522.342,526.338,530.838,535.338,537.588" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.83,0.5,0.5,0.44,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Modena, </text>
   <text y="154.101" x="310.014,317.511,322.011,326.511,330.507,335.007,339.507,341.757,344.007,347.004,349.506,354.006,356.508,360.504,362.754" svgx:width="0.83,0.5,0.5,0.44,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Modena, Italy, </text>
   <text y="151.583" x="365.005" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">7</text>
   <text y="154.103" x="367.93,375.427,379.927,382.177,388.18,392.176,396.676,399.178,403.174,406.675,408.925,411.175,416.674,423.172,429.67,431.92,437.923,440.425,442.927,445.429,449.929,452.179,456.679,460.675,463.177,465.679,470.179,472.429,476.929,481.429,483.931,488.431,490.933,494.929,497.179,501.175,503.425,507.925,511.921,514.423,516.925,521.425" svgx:width="0.83,0.5,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.72,0.72,0.25,0.67,0.28,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.28,0.44,0.25,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MS Center, AOU Città della Salute e della </text>
   <text y="165.101" x="310.015,314.515,318.511,321.013,325.009,329.509,333.01,337.51,339.76,342.01,347.014,351.514,355.015,357.517,362.017,366.517,368.767,371.017,374.014,376.516,381.016,383.518,387.514,389.764" svgx:width="0.5,0.44,0.28,0.44,0.5,0.39,0.5,0.25,0.25,0.56,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Scienza, Torino, Italy, </text>
   <text y="162.583" x="392.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">8</text>
   <text y="165.103" x="394.939,401.437,405.937,408.439,412.435,416.431,419.932,423.433,425.935,428.437,432.433,434.683,439.183,441.685,443.935,449.434,453.934,457.435,459.937,462.187,464.437,469.936,474.436,477.937,480.439,482.689,484.939,487.936,490.438,494.938,497.44" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.61,0.5,0.39,0.28,0.25,0.25,0.61,0.5,0.39,0.28,0.25,0.25,0.33,0.28,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Bari, Bari, Italy</text>
   <text y="192.103" x="310.015,316.018,320.518,324.514,329.518,334.018,337.852,342.352,347.356,352.36,357.364,360.361" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="192.103" x="363.115,369.613,373.609,376.111,380.107,382.609,385.111,389.107,393.607,400.609,404.605,409.105,411.859,414.361,417.862,420.616,423.118,427.618,431.614,434.368,441.37,445.87,449.371,451.873,454.627,458.623,461.458,464.455,468.451,472.447,474.949,477.451,481.951,485.947,488.701,493.201,496.198,500.698,505.198,507.952,510.949,515.449,518.446,521.2,524.197,528.193,530.695,534.691,539.191,542.692" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.39,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab is the most effective drug for relaps-</text>
   <text y="203.101" x="310.015,312.517,317.017,321.517,324.514,327.511,331.507,338.509,341.011,343.513,346.015,348.517,353.017,357.517,359.767,362.107,369.109,373.609,376.111,378.613,381.115,385.615,388.117,392.113,394.363,396.712,400.213,404.209,406.711,410.707,413.704,418.204,421.705,424.207,427.708,429.958,432.298,435.295,441.298,447.301,450.298,458.299,463.303,466.3,468.55,470.89,475.39,479.89,482.392,484.642,486.991,490.987,495.487,499.987,502.489,506.989,509.239,511.579,514.576,518.572,521.569,525.565,528.067,532.567,534.817,537.157,541.657,545.653" svgx:width="0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.67,0.67,0.33,0.89,0.56,0.33,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.25,0.55,0.33,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing-remitting multiple sclerosis (RR-MS) but could rarely be </text>
   <text y="214.099" x="310.015,314.011,317.512,321.013,325.513,329.509,332.011,336.007,338.509,342.505,347.005,349.255,353.926,360.424,362.926,365.428,369.928,372.178,376.849,381.349,384.346,388.846,393.346,396.343,400.339,403.84,407.341,409.843,414.343,418.339,420.589,425.26,432.262,436.762,439.264,441.766,444.268,447.265,451.765,455.761,459.757,462.259,464.509,469.18,471.682,475.678,480.178,484.678,489.178,493.174,497.674,501.67,505.666,510.166,514.666,518.662,521.164,525.664,530.164,534.16,536.662,541.162,545.662" svgx:width="0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">associated with progressive multifocal leukoencephalopathy </text>
   <text y="225.097" x="310.015,313.012,318.016,326.017,331.516,334.513,336.763,339.013,348.418,354.916,359.416,363.916,367.417,371.413,373.663,383.068,386.065,388.567,392.068,396.568,398.818,408.223,410.725,415.225,419.221,422.218,426.214,430.21,433.711,437.707,441.208,443.458,452.863,456.859,459.856,462.358,466.354,469.351,471.601,481.006,485.506,490.006,492.256,501.661,506.161,510.157,512.659,516.655,519.157,521.659,525.655,530.155,537.157,541.153,545.653" svgx:width="0.33,0.56,0.89,0.61,0.33,0.25,0.25,0.55,0.72,0.5,0.5,0.39,0.44,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PML), whose risk increases after 24 natalizumab </text>
   <text y="236.095" x="310.015,314.011,318.511,325.513,328.015,332.515,335.017,338.518,341.02,344.017,348.013,350.515,353.017,357.517,362.017,365.518" svgx:width="0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">administrations.</text>
   <text y="247.093" x="310.015,317.017,322.021,325.018,329.014,333.01,336.007,338.509,343.009,347.005,350.506,353.503" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="247.093" x="356.149,361.018,365.518,368.164,372.16,376.66,380.656,383.158,387.658,391.654,394.156,398.152,400.798,403.3,407.8,411.796,414.442,418.438,421.273,424.27,426.772,430.768,434.764,438.76,443.26,445.906,450.406,453.403,456.049,460.549,463.051,465.886,468.883,472.879,475.876,479.872,484.372,486.874,489.52,493.516,498.016,502.012,504.514,507.016,511.012,515.512,518.014,522.01,524.656,527.158,531.658,535.654,538.651,542.647" svgx:width="0.61,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.44,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To evaluate the efficacy of different available thera-</text>
   <text y="258.091" x="310.015,314.515,317.017,321.013,324.514,326.764,329.428,333.928,338.428,341.092,348.094,352.09,356.086,360.586,363.25,367.246,371.746,376.246,380.746,384.742,387.244,389.746,393.742,397.738,402.238,404.902,407.899,411.895,414.397,418.393,422.893,426.394,430.39,433.054,436.051,440.047,442.549,446.545,449.209,452.206,458.704,464.707,470.71,473.707,476.371,480.367,484.867,489.367,492.031,499.033,503.029,507.529,512.029,516.025,518.527,521.029,525.025,527.689,530.686,534.682,538.183,542.683" svgx:width="0.5,0.28,0.44,0.39,0.25,0.25,0.5,0.5,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.33,0.72,0.67,0.67,0.33,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.5,0.44,0.28,0.28,0.44,0.25,0.33,0.44,0.39,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pies, on mean annualized relapse rate (ARR) and magnetic reso-</text>
   <text y="269.089" x="310.015,314.515,318.511,323.011,327.007,331.003,333.253,335.557,338.059,345.061,349.057,353.557,356.059,360.559,365.059,367.309,369.613,372.61,380.611,386.614,389.611,392.608,394.858,397.162,401.158,405.154,407.656,410.158,414.658,417.16,419.662,424.162,426.412,428.716,432.712,435.709,438.211,442.207,445.204,447.454,449.758,454.258,458.758,461.008,463.312,467.812,471.808,474.31,478.306,480.808,483.31,487.306,491.806,498.808,502.804,507.304,509.554,511.858,516.358,520.858,524.359,528.355,531.856,534.106,536.356,538.66,541.162,545.662" svgx:width="0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.28,0.78,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.89,0.67,0.33,0.33,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nance imaging (MRI) activity after 24 natalizumab doses, in </text>
   <text y="280.087" x="310.015,314.515,318.511,321.013,323.515,327.511,332.011,334.513,338.014,340.264,346.762,349.264,351.766,356.266,358.516,364.519,370.522,373.519,381.52,386.524" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.67,0.67,0.33,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with RR-MS.</text>
   <text y="291.085" x="310.015,318.511,322.507,325.504,330.508,335.008,340.012,343.513,346.51" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="291.085" x="348.022,353.026,357.526,362.026,366.526,369.028,373.024,377.524,381.52,386.02,390.52,394.021,396.271,397.783,402.283,405.28,409.78,413.281,417.781,421.777,425.773,428.275,430.777,435.277,439.273,441.523,443.035,450.037,454.537,457.039,459.541,462.043,466.039,470.035,474.535,477.037,481.033,483.67,485.92,487.432,491.932,496.432,499.933,503.929,506.926,511.426,515.422,517.924,520.426,524.926,529.426,533.422,535.924,538.174,542.674" svgx:width="0.56,0.5,0.5,0.5,0.28,0.44,0.5,0.44,0.5,0.5,0.39,0.25,0.25,0.5,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.78,0.5,0.28,0.28,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Spontaneous, prospective, multicenter, observational,1-</text>
   <text y="302.083" x="310.015,314.515,318.511,322.507,325.504,327.754,328.996,332.497,334.999,339.499,343.999,348.499,350.749,351.991,354.493,358.993,361.243,362.485,366.481,370.981,374.977,377.479,381.979,385.975,388.477,392.473,394.723,395.965,400.465,402.967,406.468,410.464,414.46,417.961,421.957,424.207,425.449,429.445,433.945,438.445,441.442,444.943,448.939,451.189,452.431,456.931,461.431,463.681,464.923,469.423,473.923,477.424,481.42,484.921,487.171,488.413,492.913,495.91,498.16,499.402,503.902,507.898,510.4,514.396,516.898,519.4,523.396,527.896,534.898,538.894,543.394,545.644" svgx:width="0.5,0.44,0.44,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">year study to evaluate disease course 24 doses of natalizumab. </text>
   <text y="313.081" x="310.015,315.019,318.016,320.518,327.52,331.516,334.513,339.013,341.362,345.862,350.362,352.864,356.86,361.36,368.362,372.358,374.86,376.714,383.212,389.215,395.218,397.468,399.817,404.821,408.817,412.813,417.313,421.813,426.313,430.309,433.306,437.806,440.155,444.655,449.155,451.657,455.653,460.153,467.155,471.151,474.652,477.154,479.503,483.499,487.999,492.499,496.999,500.995,503.497,505.846,513.847,519.85,522.847,525.196,529.192,533.188,535.69,538.192,542.692" svgx:width="0.56,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.28,0.25,0.72,0.67,0.67,0.25,0.25,0.56,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.28,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.89,0.67,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Primary outcome: ARR. Secondary outcomes: annual MRI activ-</text>
   <text y="324.079" x="310.015,312.517,315.019,318.934,321.184,323.434,330.436,334.432,338.428,342.928,345.178,349.174,353.674,358.174,361.171,363.673,366.67,373.672,377.668,382.168,384.418,389.917,396.415,401.419,406.423,408.673,412.669,415.171,417.421,421.921,424.171,428.671,432.667,436.663,439.165" svgx:width="0.28,0.28,0.5,0.25,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.44,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ity, mean confirmed EDSS at 1 year.</text>
   <text y="335.077" x="310.015,316.513,320.509,324.01,329.014,331.516,334.513,338.014,341.011" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="335.077" x="343.594,350.092,354.592,358.588,361.585,366.085,370.585,375.085,379.585,382.582,386.578,391.078,393.661,396.163,402.661,406.657,411.157,413.659,418.159,420.742,423.739,428.239,432.739,435.736,438.319,442.819,446.815,449.317,451.819,455.815,460.315,462.817,466.318,468.568,471.151,475.651,480.151,482.653,485.236,489.736,492.733,495.316,499.816,504.316,508.816,511.399,514.396,518.392,522.388,525.385,529.885,532.387,534.889,538.885,543.385,545.635" svgx:width="0.72,0.5,0.44,0.33,0.5,0.5,0.5,0.5,0.33,0.44,0.5,0.25,0.28,0.72,0.44,0.5,0.28,0.5,0.25,0.33,0.5,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.5,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.33,0.44,0.44,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">One-hundred twenty four patients, out of 130 recruited, </text>
   <text y="346.075" x="310.015,314.011,318.511,325.513,330.013,332.515,336.511,339.013,343.009,347.509,349.534,352.036,356.536,360.532,362.557,365.554,370.054,372.556,375.058,379.558,386.056,389.053,393.553,398.053,400.078,404.074,408.574,413.074,415.099,421.597,425.593,428.59,432.586,434.611,439.111,443.611,446.113,450.109,454.105,456.607,459.109,463.609,467.605,469.63,474.13,477.127,479.152,482.653,485.155,489.151,491.653,494.155,497.656,500.158,502.66,506.656,510.652,513.154,515.179,519.175,523.675,527.671,530.173,534.673,538.174,542.17,545.671" svgx:width="0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.25,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">completed the follow-up and were objective of statistical analyses </text>
   <text y="357.073" x="310.015,314.011,318.511,323.011,327.511,332.011,336.007,338.509,342.505,347.005,349.255,350.317,354.313,358.309,362.305,366.805,369.802,374.302,376.804,381.304,385.804,388.054,389.116,391.618,396.118,398.62" svgx:width="0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">conducted according to: </text>
   <text y="357.073" x="401.932" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">1</text>
   <text y="357.073" x="406.432,409.429,411.679,412.741,415.243,419.743,423.739,425.989,427.051,431.551,435.547,439.543,442.045,445.546,448.048,452.548,457.048,459.298,460.36,462.862,467.362,469.612,470.674,474.67,479.17,483.67,486.172,488.674,493.174,497.674,501.67,504.172,508.672,511.174,514.675,518.671,523.171,527.671,530.173,532.675,537.175,541.675,545.671" svgx:width="0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.28,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) the decision to continue/discontinue </text>
   <text y="368.071" x="310.015,314.515,318.511,321.013,325.009,327.511,330.013,334.009,338.509,345.511,349.507,354.007,356.257,357.04,361.036,364.033,366.535,370.531,373.528,375.778,376.561,381.061,385.561,387.811,388.594,393.094,397.594,401.095,405.091,408.592,410.842,411.625,414.622,417.124,421.624,424.126,428.122,432.622,435.124,437.626,442.126,446.626,449.623,452.125,456.625,459.622,462.124,465.121,469.117,473.113,475.615,477.865,478.648,481.645,484.642,490.141,495.64,498.637,500.887,501.67,506.17,510.67,515.17,519.67,522.172,526.168,528.67,531.172,535.672,540.172,543.169,545.671" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.33,0.28,0.5,0.28,0.44,0.5,0.28,0.28,0.5,0.5,0.33,0.28,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.25,0.55,0.33,0.33,0.61,0.61,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.33,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab after 24 doses [intention-to-treat (ITT) population]; </text>
   <text y="379.069" x="310.015" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">2</text>
   <text y="379.069" x="314.515,317.512,319.762,322.354,324.856,329.356,333.352,335.602,338.194,340.696,343.693,347.689,351.685,354.187,361.189,365.185,369.685,372.187,374.437,377.029,380.026,384.022,388.018,392.014,394.516,399.016,403.012,407.512,409.762,412.354,416.854,421.354,424.351,426.853,431.353,435.853,438.103,440.695,443.197,447.697,451.693,453.943,456.535,461.035,465.535,469.036,473.032,476.029,480.529,484.525,487.027,489.529,494.029,498.529,500.779,503.371,507.871,511.867,514.864,517.366,521.866,526.366,528.616,531.208,534.205,538.201,542.197,545.698" svgx:width="0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) the treatment received during the observation period [“as </text>
   <text y="390.067" x="310.015,312.517,315.514,319.51,323.506,326.008,330.004,334.504,338.5,340.741,343.738,349.237,354.736,357.733,359.974,364.474,368.974,373.474,377.974,380.476,384.472,386.974,389.476,393.976,398.476,401.473,403.723,405.964,408.961,413.461,415.702,418.204,422.704,426.7,428.941,432.937,438.436,443.935,447.931,450.172,454.672,459.172,463.672,468.172,470.674,474.67,477.172,479.674,484.174,488.674,490.915,493.417,497.917,501.913,504.154,508.654,511.156,514.657,517.159,520.156,522.658,527.158,531.658,534.16,536.662,541.162,545.662" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.44,0.25,0.33,0.72,0.61,0.33,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.33,0.25,0.25,0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.72,0.61,0.44,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated” (AT) population]. In the “AT” population the distribution </text>
   <text y="401.065" x="310.015,314.515,317.512,319.474,323.974,327.97,330.472,332.974,336.97,341.47,343.972,347.473,349.435,355.933,359.929,363.43,365.932" svgx:width="0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of patients was: </text>
   <text y="401.065" x="367.894" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">1</text>
   <text y="401.065" x="372.394,375.391,379.891,383.887,386.389,388.891,392.887,397.387,399.889,403.39,405.352,409.348,413.848,418.348,420.85,423.352,427.852,432.352,434.854,439.354,443.854,445.816,450.316,454.312,456.814,460.81,463.312,465.814,469.81,474.31,481.312,485.308,489.808,491.77,496.27,500.77,503.767,506.269,510.769,515.269,517.231,519.733,524.233,528.229,530.191,534.691,538.687,542.683,545.68" svgx:width="0.33,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">)patients continuing natalizumab during the year </text>
   <text y="412.063" x="310.015,314.515,317.512,319.762,322.426,325.423,329.923,332.425,334.927,339.427,345.925,348.922,353.422,357.922,360.172,362.836,365.833,371.836,378.334,384.832,390.331,393.328,399.826,406.324,411.823,417.826,422.83,425.827" svgx:width="0.5,0.33,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.33,0.67,0.72,0.72,0.61,0.33,0.72,0.72,0.61,0.67,0.56,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of follow-up (CONTINUERS);</text>
   <text y="412.063" x="428.329" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">2</text>
   <text y="412.063" x="432.829,435.826,440.326,444.322,446.824,449.326,453.322,457.822,460.324,463.825,466.075,468.739,473.239,475.741,479.242,483.238,487.738,492.238,494.74,497.242,501.742,506.242,508.744,513.244,517.744,519.994,522.658,527.158,531.154,533.656,537.652,540.154,542.656" svgx:width="0.33,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">)patients discontinuing natali-</text>
   <text y="423.061" x="310.015,314.011,318.511,325.513,329.509,334.009,336.259,338.896,343.396,347.896,350.893,353.395,357.895,362.395,364.645,367.282,369.784,374.284,378.28,380.53,383.167,387.667,391.663,395.659,398.656,400.906,403.543,408.043,411.04,413.29,415.927,418.924,423.424,425.926,428.428,432.928,439.426,441.676,444.313,448.813,453.313,455.563,458.2,461.197,467.695,474.193,477.19,482.689,488.188,493.687,499.69,504.694,507.691" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.72,0.72,0.33,0.61,0.61,0.61,0.67,0.56,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab during the year of follow up (QUITTERS);</text>
   <text y="423.061" x="510.193" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">3</text>
   <text y="423.061" x="514.693,517.69,522.19,526.186,528.688,531.19,535.186,539.686,542.188,545.689" svgx:width="0.33,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">)patients </text>
   <text y="434.059" x="310.015,313.516,320.014,322.516,325.018,329.014,333.514,336.016,340.516,345.016,347.266,351.532,355.528,362.53,367.03,371.53,376.03,378.28,382.546,387.046,389.548,392.383,395.38,399.376,402.373,406.369,410.869,413.371,415.621,419.887,422.389,426.889,430.885,433.882,437.878,442.378,444.88,448.876,452.377,454.627,456.877,461.143,463.645,468.145,472.141,474.643,479.143,483.643,486.145,490.645,495.145,497.395,501.661,506.161,510.157,512.659,516.655,519.157,521.659,525.655,530.155,537.157,541.153,545.653" svgx:width="0.39,0.72,0.28,0.28,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.78,0.5,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">switching among different therapies, including natalizumab </text>
   <text y="445.057" x="310.015,313.012,318.016,326.512,329.509,335.008,341.011,347.509,353.008,359.011,364.015,367.012,369.262,371.512,372.7,379.198,383.698,385.948,387.136,390.637,393.139,397.639,402.139,404.641,407.638,410.14,414.136,418.132,422.632,425.134,427.384,428.572,433.072,435.574,438.409,441.406,445.402,448.399,452.395,456.895,460.891,464.887,468.388,470.638,471.817,474.319,478.819,481.069,482.257,486.757,490.753,497.755,502.255,506.755,509.752,513.748,518.248,522.748,525.25,529.246,531.496,532.684,536.68,541.18,545.68" svgx:width="0.33,0.56,0.94,0.33,0.61,0.67,0.72,0.61,0.67,0.56,0.33,0.25,0.25,0.55,0.72,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(SWITCHERS). No significant differences in demographic and </text>
   <text y="456.055" x="310.015,314.65,318.781,322.417,326.548,329.185,331.822,336.457,340.588,343.414,347.545,350.182,352.819,357.454,360.091,364.222,368.353,370.99,373.816,377.947,382.582,386.713,389.845,393.976,398.107,400.744,404.875,408.007,410.644,414.28,416.917,419.554,423.685,427.321,430.147,436.78,440.911,444.043,448.174,451.0,454.132,458.767,463.402,468.037,472.672,475.498,479.629,484.264,491.401,496.036,500.167,503.299,505.936,510.571,515.206,518.032,520.669,525.304,529.435,532.261,536.896,539.533,542.665" svgx:width="0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.39,0.28,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">baseline clinical characteristics were found comparing the dif-</text>
   <text y="467.053" x="310.015,313.147,317.278,320.41,324.541,329.176,331.813,333.892,338.527,341.659,346.294,350.929,355.564,359.2,361.279,365.914,369.046,371.125,373.762,376.894,381.025,385.156,387.793,394.93,399.061,403.696,406.333,408.718,410.635,416.269,420.904,425.035,427.114,430.246,435.88,441.352,443.431,448.066,452.701,457.336,461.971,464.608,468.739,471.376,474.013,478.648,483.283,485.362,489.493,494.128,498.259,500.896,505.531,509.167,511.804,515.44,517.519,521.155,525.79,530.425,537.058,541.189,545.689" svgx:width="0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.61,0.5,0.44,0.25,0.33,0.61,0.61,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ferent groups of treatment. The ITT population analysis showed </text>
   <text y="478.051" x="310.015,312.652,317.287,321.418,324.055,326.854,330.985,333.622,336.259,340.894,343.531,347.662,351.793,354.43,357.229,360.361,364.996,370.207,374.842,377.227,381.862,386.497,391.132,394.264,397.063,401.194,405.829,410.464,413.263,416.395,420.526,425.161,427.798,432.433,435.07,439.705,444.34,446.977,451.108,455.239,457.876,460.675,463.807,468.442,473.653,478.288,480.673,485.308,489.943,494.578,497.71,500.509,504.64,508.771,511.408,514.045,518.68,521.317,523.954,528.589,531.388,538.021,542.152,545.653" svgx:width="0.28,0.5,0.44,0.28,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">that clinical (p=0.004) and radiological (p=0.018) activity was </text>
   <text y="489.049" x="310.015,313.651,316.288,320.923,325.558,328.195,331.327,333.964,338.095,342.226,346.861,349.498,352.135,356.77,359.02,359.902,362.539,367.174,373.807,377.938,381.07,383.32,384.202,386.839,391.474,393.724,394.606,399.241,403.372,406.009,408.646,412.777,417.412,420.049,423.685,425.935,426.817,430.948,435.583,440.218,442.855,445.492,450.127,454.762,457.399,462.034,466.669,468.919,469.801,474.436,478.567,481.204,485.335,487.972,490.609,494.74,499.375,506.512,510.643,515.278,517.528,518.41,521.542,528.175,533.386,538.021,542.656,545.653" svgx:width="0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.72,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.72,0.56,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">significantly lower in patients continuing natalizumab (N=43) </text>
   <text y="500.047" x="310.015,312.652,317.287,321.418,326.053,328.69,331.327,335.962,338.599,341.236,345.871,350.506,354.142,358.273,360.91,364.546,367.183,371.818,376.453,381.088,383.725,388.36,392.995,395.632,398.269,400.906,403.543,406.675,413.308,418.519,423.154,427.789,430.921,433.396,439.03,443.665,446.302,449.938,452.575,459.712,463.843,467.974,472.609,475.246,477.883,482.014,484.651,489.286,492.418,497.053,499.69,503.821,507.952,510.589,513.226,517.861,521.992,524.629,528.76,531.73,534.862,538.993,543.124,545.626" svgx:width="0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.39,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.28,0.28,0.25,0.33,0.72,0.56,0.5,0.5,0.33,0.25,0.61,0.5,0.28,0.39,0.25,0.78,0.44,0.44,0.5,0.28,0.25,0.44,0.25,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">than in those stopping it (N=81) This meant a protective effect </text>
   <text y="511.045" x="310.015,314.65,317.782,320.032,322.516,327.151,331.282,333.919,338.05,340.687,343.324,347.455,352.09,359.227,363.358,367.993,370.243,372.727,376.858,381.493,386.128,388.765,391.402,396.037,400.672,404.803,407.44,410.077,414.712,419.347,421.597,424.081,428.716,433.351,435.601,438.085,442.216,444.853,447.49,452.125,454.762,458.893,463.024,465.661,467.911,470.395,474.526,478.657,481.294,483.931,488.566,491.203,493.84,498.475,500.725,503.209,506.341,510.976,515.611,520.246,523.882,526.132,528.616,531.748,535.879,538.516,541.153,545.653" svgx:width="0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.5,0.5,0.5,0.39,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of natalizumab continuation on clinical activity (odds ratio </text>
   <text y="522.043" x="310.015,313.147,319.78,325.918,329.05,331.435,336.07,338.455,343.09,347.725,350.362,353.143,357.778,362.413,370.045,372.826,376.957,381.592,386.227,389.359,391.996,396.631,400.762,405.397,409.528,413.659,416.44,419.077,423.712,426.349,430.48,433.612,438.247,442.378,445.015,447.796,450.928,457.066,460.198,463.33,465.715,470.35,472.735,477.37,482.005,485.137,489.772,492.157,496.792,501.427,504.559,507.34,511.471,516.106,520.741,523.522,526.654,530.785,535.42,538.057,542.692" svgx:width="0.33,0.72,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.83,0.25,0.44,0.5,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.33,0.67,0.33,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(OR),0.33; 95% confidence interval (CI),0.15-0.70) and radio-</text>
   <text y="533.041" x="310.015,312.652,317.287,321.922,324.559,328.69,332.821,335.458,338.068,342.199,346.33,348.967,351.604,356.239,358.876,361.513,366.148,368.758,371.89,378.523,384.661,387.046,391.681,394.066,398.701,403.336,405.973,410.608,415.243,422.875,429.013,432.145,434.53,439.165,441.55,446.185,450.82,453.952,458.587,460.972,465.607,470.242,473.374,475.759,478.207,483.841,488.476,492.607,495.217,499.348,504.982,510.616,514.747,517.357,521.992,526.627,531.262,535.897,538.534,542.665" svgx:width="0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.72,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.5,0.5,0.83,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.72,0.61,0.44,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">logical activity (OR,0.35;95%CI,0.15-0.79). The “AT” popula-</text>
   <text y="544.039" x="310.015,312.652,315.289,319.924,324.559,326.809,328.303,332.434,337.069,341.2,343.837,348.472,352.108,354.745,358.381,360.631,362.125,365.761,370.396,375.031,381.664,385.795,390.43,392.68,394.174,396.811,401.446,405.577,408.214,410.464,411.958,416.089,418.726,421.363,425.998,428.635,432.766,436.897,439.534,441.784,443.278,446.41,451.045,456.256,460.891,463.276,467.911,472.546,477.181,480.313,482.563,484.057,488.188,492.823,497.458,499.708,501.202,504.334,508.465,513.1,515.737,520.372,523.009,527.644,532.279,534.916,539.047,543.178,545.68" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion analysis showed that clinical (p=0.003) and radiological </text>
   <text y="555.037" x="310.015,314.146,318.277,320.914,323.551,328.186,330.823,333.46,338.095,340.345,341.281,344.413,349.048,354.259,358.894,361.279,365.914,370.549,375.184,378.316,380.566,381.502,388.135,392.266,395.398,399.529,401.779,402.715,406.351,408.988,413.623,418.258,420.895,424.027,426.664,430.795,434.926,439.561,442.198,444.835,449.47,451.72,452.656,455.293,459.928,466.561,470.692,473.824,476.074,477.01,479.647,484.282,486.532,487.468,493.606,500.239,506.872,512.506,515.638,522.271,528.904,534.538,540.676,545.68" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.72,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.72,0.72,0.61,0.33,0.72,0.72,0.61,0.67,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activity (p=0.002) were significantly lower in CONTINUERS </text>
   <text y="566.035" x="310.015,312.652,317.287,321.418,326.053,328.717,331.354,335.989,338.653,345.286,351.919,355.051,360.685,366.319,371.953,378.091,383.23,385.894,390.529,393.661,396.325,398.962,403.597,406.261,411.4,420.031,423.163,428.797,434.935,441.568,447.202,453.34,458.479,460.864,463.366,469.0,473.635,476.272,479.908,482.572,486.703,491.338,495.973,499.105,501.742,504.874,512.011,516.142,520.777,523.441,527.572,530.236,534.871,538.003,542.638" svgx:width="0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.72,0.33,0.61,0.61,0.61,0.67,0.56,0.25,0.5,0.33,0.25,0.28,0.5,0.25,0.56,0.94,0.33,0.61,0.67,0.72,0.61,0.67,0.56,0.25,0.25,0.61,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.44,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">than in QUITTERS or in SWITCHERS. This confirmed a pro-</text>
   <text y="577.033" x="310.015,312.652,316.783,320.914,323.551,326.188,330.823,334.954,337.024,341.155,344.125,347.257,351.388,355.519,358.156,360.226,364.861,369.496,371.566,374.203,378.838,382.969,385.039,388.171,390.808,394.444,399.079,401.149,405.784,408.916,410.986,414.118,418.249,420.886,425.017,429.652,433.288,437.419,439.489,442.126,446.761,448.831,454.969,461.602,468.235,473.869,477.001,483.634,490.267,495.901,502.039,507.178,509.248,513.379,518.014,525.151,529.786,533.917,537.049,541.18,545.68" svgx:width="0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.67,0.72,0.72,0.61,0.33,0.72,0.72,0.61,0.67,0.56,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tective effect on the risk of relapse in CONTINUERS compared </text>
   <text y="588.031" x="310.015,312.652,317.287,319.537,321.049,327.682,334.315,337.447,343.081,348.715,354.349,360.487,365.626,367.876,369.388,372.52,379.153,385.291,387.676,392.311,394.696,399.331,403.966,406.603,411.238,415.873,423.505,429.643,432.775,435.16,439.795,442.18,446.815,451.45,454.582,458.884,463.519,465.904,470.539,475.174,478.306,480.556,482.068,486.703,489.835,492.085,493.597,498.736,507.367,510.499,516.133,522.271,528.904,534.538,540.676,545.68" svgx:width="0.28,0.5,0.25,0.55,0.72,0.72,0.33,0.61,0.61,0.61,0.67,0.56,0.25,0.55,0.33,0.72,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.5,0.5,0.83,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.94,0.33,0.61,0.67,0.72,0.61,0.67,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to QUITTERS (OR,4.40;95%CI,1.72-11.23) or SWITCHERS </text>
   <text y="599.029" x="310.015,313.012,319.51,325.513,327.763,332.263,334.513,339.013,343.513,346.015,350.515,355.015,362.512,368.515,371.512,373.762,378.262,380.512,385.012,389.512,392.509,397.009,401.509,403.759,408.259,412.759,415.756,418.006,420.886,427.384,431.884,435.88,438.76,443.764,451.765,456.931,459.811,466.309,470.305,473.806,476.686,481.186,485.686,489.187,493.183,496.18,500.68,504.676,509.176,511.426,514.306,520.804,523.306,525.808,530.308,533.188,536.185,540.685,543.187,545.689" svgx:width="0.33,0.72,0.67,0.25,0.5,0.25,0.5,0.5,0.28,0.5,0.5,0.83,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.72,0.5,0.44,0.25,0.56,0.89,0.61,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.5,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(OR,3.28;95%CI,0.99-10.79). One PML was observed, with full </text>
   <text y="610.027" x="310.015,313.012,317.008,321.004,325.504,330.004,334.0,336.997,341.497,343.747,348.247,351.244,353.494,357.994,361.99,366.49,369.487,373.987,376.489,380.989,385.489,387.991,391.987,395.983,398.485,400.735,404.236,406.738,411.238,415.738,419.239,421.489,425.485,429.985,434.485,436.735,440.236,444.736,451.738,456.238,458.74,463.24,470.242,473.743" svgx:width="0.33,0.44,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">recovery of neurological signs and symptoms.</text>
   <text y="621.025" x="310.015,316.513,321.013,326.017,330.013,332.515,337.519,341.02,343.522,348.022,353.026,356.527,359.524" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="621.025" x="363.835,369.838,372.34,374.842,379.342,381.844,385.84,389.836,392.338,394.588,396.649,400.645,405.145,409.645,411.895,413.956,421.957,427.96,430.957,433.207,435.268,438.265,442.261,446.257,450.253,452.755,455.257,459.757,463.753,466.255,468.757,473.257,477.757,480.007,482.068,486.568,490.564,494.56,499.06,502.057,505.558,507.808,509.869,516.871,521.371,524.368,528.364,530.614,532.675,535.672,538.669,542.665" svgx:width="0.67,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.67,0.33,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.39,0.25,0.55,0.78,0.5,0.33,0.44,0.25,0.55,0.33,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Clinical and MRI reactivation occurs more fre-</text>
   <text y="632.023" x="310.015,314.515,319.015,323.011,327.511,330.013,332.515,337.015,339.346,341.848,346.348,348.679,353.179,357.175,359.677,362.179,366.175,370.675,373.177,376.678,379.009,382.51,385.012,389.512,394.012,398.512,401.014,405.514,410.014,412.345,416.845,420.841,423.343,427.339,429.841,432.343,436.339,440.839,447.841,451.837,456.337,458.668,461.17,465.67,469.666,474.166,476.497,478.999,483.499,485.83,488.332,492.832,497.332,500.833,504.829,507.16,511.156,515.656,520.156,522.658,525.16,529.66,534.16,536.662,541.162,545.662" svgx:width="0.5,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.39,0.44,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">quently in patients stopping natalizumab than in those continuing </text>
   <text y="643.021" x="310.015,312.517,315.019,317.269,318.916,324.415,328.915,332.911,335.908,339.904,344.404,348.904,350.713,355.213,357.715,361.216,365.212,369.712,374.212,376.714,379.216,383.716,388.216,392.212,394.714,397.216,401.716,406.216,408.025,411.526,416.026,420.526,425.026,427.528,432.028,433.837,438.337,442.333,444.142,448.138,452.638,457.138,460.639,463.141,467.641,471.637,474.634,478.63,483.13,484.939,489.439,493.939,496.441,500.941,502.75,505.252,508.249,510.058,512.56,517.06,521.056,522.865,525.862,528.364,531.865,536.365,538.174,542.674,545.671" svgx:width="0.28,0.28,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.39,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.28,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">it. Therapy discontinuation should be considered only if the risk of </text>
   <text y="654.019" x="310.015,315.019,323.02,328.186,330.436,332.938,336.439,338.689,343.189,345.691,350.191,354.691,356.941,360.937,365.437,369.937,372.187,376.687,381.187,383.689,390.187,394.183,396.685,401.185,405.685,409.186,411.436,413.938,418.438,422.434,424.684,429.184,433.18,437.68,441.676,444.673,447.175,449.677,453.178,455.428,459.928,462.925,465.175,469.171,473.671,478.171,480.673,483.175,487.675,492.175,494.677,499.177,503.677,505.927,508.429,512.929,516.925,519.175,523.675,526.672,531.172,535.672" svgx:width="0.56,0.89,0.61,0.25,0.28,0.39,0.25,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.28,0.72,0.44,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.33,0.28,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PML is high and outweighs the benefits of continuing the drug.</text>
   <text y="681.019" x="310.015,315.514,320.014,324.514" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P864</text>
   <text y="692.017" x="310.015,316.513,319.015,322.516,327.52,329.77,334.27,337.267,339.517,343.513,347.509,350.011,354.511,359.515,363.016,367.012,369.262,373.762,376.759,379.756,383.752,387.748,389.998,395.002,399.502,402.499,406.999,409.501,412.003,415.999,421.003,428.5,433.0,438.004,440.254,445.258,447.76,451.261,455.257,459.757,464.761,467.758,470.26,475.264,480.268,484.768,487.765,490.267,494.767,499.771,502.768" svgx:width="0.72,0.28,0.39,0.56,0.25,0.5,0.33,0.25,0.44,0.44,0.28,0.5,0.56,0.39,0.44,0.25,0.5,0.33,0.33,0.44,0.44,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.25,0.56,0.28,0.39,0.44,0.5,0.56,0.33,0.28,0.56,0.56,0.5,0.33,0.28,0.5,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Risk of relapse after natalizumab discontinuation: </text>
   <text y="703.015" x="310.015,316.513,321.517,324.019,328.015,333.019,335.269,337.771,341.272,343.522,346.519,351.523,355.519,357.769,362.773,366.769,370.27,373.267,375.517,378.514,382.51,386.506,391.006,394.003,401.5,405.496,410.5,413.497,415.747,420.247,425.251,428.248,430.75,435.25,440.254" svgx:width="0.72,0.56,0.28,0.44,0.56,0.25,0.28,0.39,0.25,0.33,0.56,0.44,0.25,0.56,0.44,0.39,0.33,0.25,0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.25,0.5,0.56,0.33,0.28,0.5,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">which is the best treatment option?</text>
   <text y="714.013" x="310.015,315.019,317.269,320.266,324.262,327.259,330.256,334.252,336.754,341.254,345.25,349.75" svgx:width="0.56,0.25,0.33,0.44,0.33,0.33,0.44,0.28,0.5,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">P Iaffaldano</text>
   <text y="711.583" x="354.25" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="714.103" x="357.175,359.425,361.675,368.173,370.423,375.922,379.918,384.418,388.918,391.915" svgx:width="0.25,0.25,0.72,0.25,0.61,0.44,0.5,0.5,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, V Lepore</text>
   <text y="711.583" x="395.91" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="714.103" x="398.836,401.086,403.336,409.833,412.083,417.582,422.082,426.078,428.581,432.082,436.078,440.578" svgx:width="0.25,0.25,0.72,0.25,0.61,0.5,0.44,0.28,0.39,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Lucisano</text>
   <text y="711.583" x="445.077" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="714.103" x="448.002,450.252,452.502,458.505,460.755,465.759,470.259,474.255,478.251,480.753,483.255,485.757" svgx:width="0.25,0.25,0.67,0.25,0.56,0.5,0.44,0.44,0.28,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Pozzilli</text>
   <text y="711.583" x="488.259" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="714.103" x="491.184,493.434,495.684,502.182,504.432,510.435,513.432,517.428,520.929,524.925,527.427,531.423" svgx:width="0.25,0.25,0.72,0.25,0.67,0.33,0.44,0.39,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, V Brescia </text>
   <text y="725.101" x="310.014,318.015,322.515,325.512,328.509" svgx:width="0.89,0.5,0.33,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Morra</text>
   <text y="722.583" x="332.506" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="725.103" x="335.431,337.681,339.931,346.429,348.679,355.177,359.677,363.673,367.669,371.665" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.44,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Ghezzi</text>
   <text y="722.583" x="374.167" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="725.103" x="377.092,379.342,381.592,387.091,389.341,397.342,399.844,402.346,404.848,408.844,411.841,414.343,418.843,421.84,424.342,428.842" svgx:width="0.25,0.25,0.61,0.25,0.89,0.28,0.28,0.28,0.44,0.33,0.28,0.5,0.33,0.28,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Millefiorini</text>
   <text y="722.583" x="431.343" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="725.103" x="434.268,436.518,438.768,443.772,446.022,451.026,455.022,457.524,460.026" svgx:width="0.25,0.25,0.56,0.25,0.56,0.44,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Patti</text>
   <text y="722.583" x="462.528" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">7</text>
   <text y="725.103" x="465.453,467.703,469.953,476.451,478.701,484.2,488.7,493.2,497.196,500.193,504.189,507.69" svgx:width="0.25,0.25,0.72,0.25,0.61,0.5,0.5,0.44,0.33,0.44,0.39,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Lugaresi</text>
   <text y="722.583" x="510.191" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">8</text>
   <text y="725.103" x="513.117,515.367,517.617" svgx:width="0.25,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
  </g>
 </g>
</svg>
